RA CAPITAL MANAGEMENT, L.P.

Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

14 Aug 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 0% ownership of the company. In their previous filing dated 15 May 2025, RA CAPITAL MANAGEMENT, L.P. had reported owning 3,206,271 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	0%	-100%	$0	0	-3,206,271	-100%	$14.24	13G/A	30 Jun 2025	14 Aug 2025, 18:13
RA Capital Management, L.P.	7%		$34,499,476	3,206,271			$10.76	13G/A	31 Mar 2025	15 May 2025, 16:53

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.59%	$0	0	-3,206,271	-100%	$21.14	Q2 2025
31 Mar 2025	0.59%	+0.59%	$35,461,357	3,206,271	+3,206,271	NEW	$11.06	Q1 2025
30 Sep 2024		-0.68%	$0	0	-3,083,430	-100%	$21.14	Q3 2024
30 Jun 2024	0.68%	0%	$51,739,955	3,083,430	0		$16.78	Q2 2024
31 Mar 2024	0.59%	0%	$46,251,450	3,083,430	0		$15.00	Q1 2024
31 Dec 2023	0.72%	+0.37%	$46,251,450	3,083,430	+1,599,733	+108%	$15.00	Q4 2023
30 Sep 2023	0.41%	+0.41%	$20,786,595	1,483,697	+1,483,697	NEW	$14.01	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.